GenBio Launches a “Virtual Cell” AI Model

Back to Devoured - August 19, 2026

DEVOURED

GenBio Launches a “Virtual Cell” AI Model

GenBio is building a 'virtual cell' that simulates biological responses, aiming to accelerate pharmaceutical drug discovery and research.

What: The AIDO Cell model by GenBio simulates biological states and perturbations for K562 and HepG2 cell lines. The company is launching an early-access program for academics and biotech firms to use the platform to predict the downstream consequences of genetic or molecular interventions.

Why it matters: Modeling biological systems as computational 'world models' could drastically reduce the trial-and-error cycle of bench biology by allowing researchers to filter hypotheses in silicon before entering a physical lab.

Decoder

Perturbation: A change in the state of a biological system, such as a gene knockout, drug application, or environmental stress, used to observe the resulting response.
Immortalized cell line: A population of cells from a multicellular organism which would normally not proliferate indefinitely but, due to mutation, have evaded normal cellular senescence.

Original article

GenBio has announced a world model of a cell that can simulate both its natural state and responses to successive perturbations. AIDO Cell currently supports K562 and HepG2, two of the most widely used immortalized human cell lines in biomedical research. GenBio is preparing to launch an early-access academic collaborator program for scientists across academia, biotech, and pharma. AIDO Cell and similar systems could eventually become powerful tools for basic biological research, allowing scientists to perturb genes, proteins, or pathways, follow the predicted consequences across biological levels, generate hypotheses, and identify relationships that might take much longer to uncover in the lab.

Explore all 56 articles in today's digest